Advertisement

Topics

Milestone for Dyadic International as it begins trading on Nasdaq

11:50 EDT 17 Apr 2019 | Proactive Investors

Dyadic International Inc's (NASDAQ:DYAI) chief operating officer Matthew Jones speaks to Proactive London during what's been a significant week for the company as it begins trading on Nasdaq.

The Jupiter, Florida-based biotechnology platform company, engages in the development, and large scale manufacture of low-cost enzymes and other proteins for diverse market opportunities in the United States and Europe.

Original Article: Milestone for Dyadic International as it begins trading on Nasdaq

NEXT ARTICLE

More From BioPortfolio on "Milestone for Dyadic International as it begins trading on Nasdaq"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...